Visceral leishmaniasis is a neglected tropical disease (NTD) caused by and that is lethal in cases of nontreatment. The treatments are limited by serious drawbacks involving safety, resistance, stability, and high costs. In this work, we aimed to identify inhibitors of methionyl-tRNA synthetase (MetRS), a validated molecular target for leishmaniasis drug discovery, using a combination of strategies.
View Article and Find Full Text PDFLeishmaniasis is a neglected tropical disease that kills more than 20,000 people each year. The chemotherapy available for the treatment of the disease is limited, and novel approaches to discover novel drugs are urgently needed. Herein, 2D- and 4D-quantitative structure-activity relationship (QSAR) models were developed for a series of oxazole and oxadiazole derivatives that are active against , the causative agent of visceral leishmaniasis.
View Article and Find Full Text PDF